Full Breakdown
McDonald's Adapts Menu for Growing GLP-1 Drug User Base
2/13/2026, 4:41:23 AM
Shift in Consumer Behavior
McDonald's Corporation is responding to the increasing number of Americans using GLP-1 weight-loss medications, such as Ozempic and Wegovy, by testing new high-protein menu items. During a recent earnings call, CEO Chris Kempczinski highlighted that the adoption of these drugs has led to significant changes in consumer eating habits, with users favoring protein-rich meals and smaller portion sizes. As of late last year, approximately 12.4% of Americans reported using these medications, a figure that has more than doubled in recent years, according to a Gallup survey.
Menu Innovations
To cater to this demographic, McDonald's is exploring options that include grilled chicken strips, cauliflower tortillas, and smaller burgers wrapped in lettuce. Vice President Jill McDonald noted that the chain already offers several high-protein items, such as Snack Wraps and Sausage Biscuit sandwiches. Kempczinski emphasized that as GLP-1 adoption grows, consumer behavior will continue to evolve, leading to less snacking and a preference for lower-sugar beverages.
Industry Context
McDonald's is not alone in this trend; other fast-food chains are also adapting their menus. Chipotle has introduced a GLP-1-friendly menu featuring high-protein options, while Shake Shack launched a "Good Fit Menu" with lettuce-wrapped burgers. Starbucks has added Protein Cold Foams and Protein Lattes to its offerings. This shift reflects a broader movement within the food industry to appeal to health-conscious consumers, particularly in light of Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" initiative.
Financial Performance Amid Changes
Despite the potential challenges posed by the rise of GLP-1 medications, McDonald's reported a 5.7% increase in global comparable sales in its latest quarter, with revenue reaching approximately $7 billion. The company's stock price remained stable following the earnings announcement, indicating resilience in its business model. Analysts noted that the popularity of budget-friendly options, such as the $5 meal deal, has helped sustain sales amid rising grocery costs.
Criticism & Opposition
While McDonald's is optimistic about adapting to the GLP-1 trend, some critics argue that the fast-food industry should focus more on overall health and nutrition rather than merely adjusting to new consumer preferences. Concerns have been raised about the long-term implications of promoting high-protein fast food, especially as public health initiatives increasingly emphasize balanced diets.
Official Statements & Responses
Kempczinski stated, "As adoption grows, we know that consumers' behavior changes," highlighting the need for McDonald's to innovate in response to shifting dietary preferences. Jill McDonald added that the company is actively developing long-term strategies to serve this emerging customer segment, although specific details remain undisclosed.
What's Next
As McDonald's continues to test and refine its menu offerings for GLP-1 users, the company is expected to monitor consumer feedback closely. This ongoing experimentation may lead to permanent additions to the menu, reflecting the evolving landscape of consumer health and dietary choices.
